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Case report

Catastrophic antiphospholipid syndrome (CAPS) – A case
report
Belisha Dmello, Latha T*, B Ananthakrishna Shastri
Email: latha.tbhat@manipal.edu

Abstract
Catastrophic antiphospholipid syndrome is a rare disease with positive antiphospholipid antibodies that progresses to
a life-threatening condition resulting in multiple organ dysfunction and thromboses. Here is a 19-year young woman
who presented to the emergency room in a haemodynamically unstable condition requiring immediate mechanical
ventilator support. She had involvement of the disease in the respiratory, cardiovascular, renal, and central nervous
systems. She also developed gangrene of the left toes for which amputation was done. She was successfully treated
with Dexamethasone Cyclophosphamide Pulse (DCP) therapy. The collaborative care by the health team members in
the intensive care unit was successful in preventing complications and enhancing speedy recovery.
Keywords: Antiphospholipid syndrome, collaborative care, gangrene, plasmapheresis, pulse therapy

Introduction
Antiphospholipid syndrome (APS) is an autoimmune
disease with clinical manifestation of venous or
arterial thrombosis with the persistent presence of
antiphospholipid antibody (Cervera et al., 2009).
Catastrophic antiphospholipid syndrome (CAPS) is the
most severe form of APS also known as Asherson’s
syndrome. It was first discovered by Ronald Asherson
in 1992. It is a life-threatening complication with
occurrence less than 0.8% to 1% of patients with
APS and has a mortality of about 50% (Asherson,
2005). APS is an acute and complex biological process
leading to the occlusion of small vessels of various
organs. Thrombotic microangiopathy multiple organ
thromboses are the features seen in patients. In some
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patients, it causes tissue necrosis and is considered
an extreme or catastrophic variant of APS (Strakhan
et al., 2014). The condition presents with features of
disseminated intravascular coagulopathy (DIC) or
thrombotic thrombocytopenic purpura (TTP) that
should be treated immediately to prevent mortality
(Limper et al., 2019).

Case details
Case presentation
The present case is a 19-year female unmarried who
was bought to the emergency room in an unconscious
state. She had a history of fever, chills, and rigours for
three days. Her Glasgow coma scale (GCS) was eight
(E2V1M5). Immediate care with ventilator support
on Synchronized Intermittent Mechanical Ventilation
(SIMV) with 100% fraction of inspired oxygen (FiO2),
Positive End-Expiratory Pressure (PEEP) 5 cm
H2O was provided. Her vitals were pulse-135 bpm,
respiration – 20 bpm, blood pressure -140/80 mmHg
and the temperature was 98.6°F. The patient had
blackish discolouration of the great toe, 2nd and 3rd
toes of the right lower limb, and in the left ankle region
for three months. She had no comorbid illness and no
significant past medical history.
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Relevant investigation
On admission, laboratory values were as followshaemoglobin 9.1 gm/dl, haematocrit 28.0%, platelet
count 40.0x103/µl, total white blood cells 13.7x103 /µl,
neutrophils 93.3%, red blood cells 231 mg/dl, thyroidstimulating hormone 4.470 µIu/ml, C-reactive protein
16 mg/l, NTPRO-BNP >35000 pg/ml, Troponin T
1.580 ng/ml, and 24 hour urine protein 658 mg/24
hour. Coagulation and haemostasis tests were done and
prothrombin time (PT) was 14.4 sec and APTT tested
with an optical method showed normal value (29.6 sec)
and a test for lupus anti-coagulant showed a positive
result.
Antinuclear antibody (ANA) workup showed positive
APLA IgM. Anti-neutrophilic cytoplasmic antibody
(ANCA) showed a 1:10 ratio, which suggested
a negative result. ELISA for anti-neutrophilic
cytoplasmic antibody (ANCA) titre for IgG antibody
against myeloperoxidase (MPO) and proteinase 3 (PR3)
and antibodies to dsDNA showed negative results.
Antibodies to cardiolipin IgM titre value and ACA
IgG value were positive and electroencephalogram
(EEG) revealed severe diffuse encephalopathy.
Electrocardiogram (ECG) was normal except for ‘T’
wave inversion.
2-D echo report on 3rd day of admission showed
globally hypokinetic left ventricle, moderate left
ventricular systolic dysfunction, severe mitral
regurgitation and mild tricuspid regurgitation and
diagnosed to have a congestive cardiac failure. A repeat
echo on the 19th day of admission showed globally
hypokinetic left ventricle, moderate to severe left
ventricular systolic dysfunction, moderate to severe
mitral regurgitation and right ventricular dysfunction
with moderate tricuspid regurgitation. The ejection
fraction was 33%.
Right vesicoureteric junction calculus and proximal
ureteric calculus and minimal hydroureteronephrosis,
bilateral tiny non-obstructive renal calculus and
multiple para-aortic, aortocaval and retrocaval lymph
nodes were seen in CT kidney ureter bladder (KUB).
Plain CT brain revealed multiple ill-defined scattered
areas of intra axial hypodensities involving both
grey and white matter with loss of grey-white matter

differentiation in cerebral hemispheres, brainstem
and cerebellum suggesting multiple infarcts. Based
on the above findings, the initial diagnosis was sepsis
with septic shock, acute kidney injury, and suspected
vasculitis and was admitted to the intensive care unit
for further management.
Case management
The 19-year young women brought to the emergency
room was unconscious with a Glasgow coma scale
reading eight (eye-opening 2, verbal response 1, and
motor response 5) and hypotension, and was managed
with noradrenaline 8 mg in 42 ml in sodium chloride
at 4 ml per hour. Injection Fentanyl citrate 100 mg and
Ketamine 50 mg were administered intravenously during
intubation and Tazillin (Piperacillin/Tazobactam) 4.5
gm in 500 ml diluted in sodium chloride intravenous
bolus was administered because of septic shock.
Injection sodium bicarbonate 200 ml was administered
to correct metabolic acidosis. Once the patient was
stabilized, she was shifted to the medical intensive care
unit for further management.
In ICU, she was given Methylprednisolone a corticosteroid 500 mg in 250 ml sodium chloride to reduce
inflammation. Injection Enoxaparin sodium 0.4 ml
subcutaneous was administered prophylactically
to prevent deep vein thrombosis. The patient was
tracheotomized given prolonged ventilation. On the
2nd day of admission, the patient had an episode of
seizure for which she had received intravenous injection
Levetiracetam 500 mg 12 hourly. Meropenem 1 gm
intravenous 12th hourly, injection Clindamycin 600
mg intravenous 8th hourly and intravenous injection
Tazillin (Piperacillin sodium/Tazobactam sodium)
2.25 gm 6th hourly was given to manage the infection.
Salbutamol nebulization was given 6th hourly to treat
hyperkalaemia. In the course of treatment, the patient
developed anaemia for which she was transfused
with packed red blood cell on the 11th and 12th day
of admission. The patient was administered fresh
frozen plasma on the 6th, 8th, 12th, and 15th day of
admission. The patient developed heparin-induced
thrombocytopenia; hence, injection Enoxaparin
sodium was stopped and changed the drug to low
molecular weight heparin (LMWH) Fondaperinux 5 mg
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subcutaneous. The patient underwent plasmapheresis
on the 6th, 7th, 9th, 13th, and 16th day of admission.
High potassium levels were managed by haemodialysis
on the 6th day of admission. The patient was started on
Mesna 200 mg in 100 ml of sodium chloride over two
hours. Simultaneously, Ondansetron 4 mg intravenous
stat followed by injection Cyclophosphamide 500 mg
in 500 ml sodium chloride over 6-8 hours intravenous
infusion on 27th and 32nd day of admission were
given. The patient was haemodynamically stable but
the Glasgow coma scale was E1VTM1.
The patient had developed multidrug-resistant Klebsiella
infection on endotracheal culture, which was managed
by injection Tazillin (Piperacillin/Tazobactam) 4.5 gm
intravenous 8th hourly in 100 ml sodium chloride. The
patient developed hypertension, which was treated with
tab Arkamin 100 mg QID and Amlodipine 5 mg SOS.
The patient had developed gangrene of the toes, which
had to be amputated to prevent further complications.
In the course of the hospital stay, the patient had
developed acute respiratory distress syndrome and
was managed by ventilator support and frequent chest
physiotherapy was given to maintain lung hygiene.
Limb physiotherapy was given to prevent bed rest
complications and to maintain mobility and properties
of joints and muscles. The patient was weaned off
from the ventilator on the 17th day of admission. With
all these treatment modalities, the patient progressed to
improve with GCS E4V5M6. She developed blurred
vision. However, she was able to walk with support and
do her daily activities of living with minimal assistance.
She was discharged with tablet Amlodipine 5 mg, tablet
Clonidine 100 mg, and tablet Levetiracetam 500 mg
twice daily; Elemental iron with folic acid, Prednisolone
10 mg, Calcium 500 mg with vitamin D3, and Aspirin
75 mg once a day; Alendronate Sodium 35 mg once
a week, syrup Levodropropizine 2 teaspoon twice
daily, and paracetamol if necessary to continue for one
month. The patient was called for follow up after a
month. She was also advised to consume a low salt diet
and to avoid green leafy vegetables and all yellow fruits.
Interdisciplinary nursing care involved the overall wellbeing of the patient and family. The problems identified
were congestive cardiac failure, septic shock, gangrene,
64

and central nervous system involvement, loss of vision,
acute respiratory distress syndrome, lung collapse,
metabolic acidosis and acute kidney injury. Nursing
care was delivered based on the problems identified as
shown in Table 1.
The catastrophic antiphospholipid antibody is a
syndrome of multiple vascular occlusions associated
with high titres of antiphospholipid antibodies
(APLA). Presentation of catastrophic antiphospholipid
antibody syndrome is often complex as it involves
multiple organs over a short period typically a few
days to weeks (Oliveira, Correia, & Oliveira, 2020).
The most characteristic involvement in catastrophic
antiphospholipid antibody syndrome is of renal,
pulmonary, cerebral and gastrointestinal vessels. The
central nervous system is involved and is manifested
by the presence of cerebral infarctions. Micro thrombi
and micro infractions are observed in catastrophic
antiphospholipid antibody syndrome which results
in thrombotic events in microcirculation leading to
gangrenes and amputation (Asherson et al., 2001). The
present case also showed similar findings involving
multiple infarcts in the brain, gangrene in the foot
requiring amputation of the toes of the left foot.
The present case had high potassium and urea, which was
treated with haemodialysis. The patient had undergone
five cycles of plasmapheresis because of high titres
for ANA. The dexamethasone- cyclophosphamide
pulse (DCP) therapy regimen was started as there was
no improvement with plasma-pheresis. The treatment
involved intravenous administration of Mesna before
starting DCP to prevent bladder bleeding and antiemetic to prevent nausea and vomiting which is a
complication of DCP. Post administration of DCP,
the same regimen was followed and the patient had
shown significant improvement with a decrease in the
symptoms. In the course of the treatment, the patient
had developed left lung collapse, which was recovered
with ventilator management and chest physiotherapy.
There was a significant improvement in the level of
consciousness and the general condition of the patient
with the ability to carry out the activities with minimal
assistance. As challenging as the case may be, we have
seen a significant improvement in the condition of the
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patient clinically. Presently the patient was conscious,
oriented and able to move in bed. The patient was
discharged from the hospital while she was able
to carry out her activities with minimal assistance.
Comprehensive nursing care involved preventing bed
rest complications, hospital-associated infections, and

bowel and bladder dysfunction by providing the patient
with oral care, tracheostomy care, and psychological
support for both patient and family members. An
interdisciplinary approach is crucial in improving the
patient’s condition.

Table 1: The systems affected and the care provided
System
affected
Problems
identified

Cardiovascular
system
·

Congestive cardiac
failure (CCF)
Gangrene
T-wave inversion
Septic shock

·
·
·

Focus of
care









Outcome

*
*
*
*

Central nervous system
·
·
·

Decreased
intravascular
volume:
Administration
of IV fluids and
monitor fluid status
Decreased preload
and decreased
afterload: Monitor
fluid and electrolyte
status through
laboratory
investigations,
administer oxygen,
maintain intake and
output chart.
Improving gas
exchange and
oxygenation
Reduce anxiety
Balancing rest and
activity
Monitoring for
cardiac arrhythmias
CCF resolved
Gangrene treated
with amputation
No new arrhythmias
Recovered from
septic shock







*
*
*
*

·
·

Altered GCS
Encephalopathy
Motor and sensory
impairment
Vision loss

·

Respiratory system

·

Monitoring ICP
Assessing GCS
Prevention of pressure
sores
Providing other means
of communication
Maintaining joint
mobility by passive
range of motion
exercise

Improved GCS score
to 15
Treated encephalopathy
Improved motor and
sensory impairment
Blurred vision

Conclusion
In conclusion, catastrophic antiphospholipid antibody
syndrome in the present case has involved the brain,
kidney, heart and lungs. Treatment strategies with
the support of mechanical ventilator, haemodialysis,
plasmapheresis, and immunoglobulin high standard
collaborative care has given a better result though the
literature shows poor prognosis.

Infection
Acute respiratory
distress syndrome
Lung collapse








*
*
*

Renal system
·
·
·

Monitoring
respiratory state
Humidification
Ventilator support
and care
Positioning
Nebulisation
Chest physiotherapy

Free from infection
Recovered from
ARDS
Good air entry to
bilateral lungs

Metabolic acidosis
Renal calculi
Acute kidney injury






*
*
*

Maintaining intake
and output
Correction
of electrolyte
imbalance
Monitoring arterial
blood gas analysis
Care during
haemodialysis

Corrected metabolic
acidosis
Renal calculi still
present
Reverted AKI to
normal function
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